Document Detail

Split-thickness skin graft donor sites: a comparative study of two absorbent dressings.
MedLine Citation:
PMID:  18065019     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To identify the optimal dressing for split-thickness skin graft (SSG) donor sites. METHOD: This prospective randomised controlled trial compared two dressings - a new absorbent form of a polyurethane film dressing (Tegaderm Absorbent, 3M) and our standard alginate dressing (Kaltostat, ConvaTec) - on SSG donor sites in 40 patients. Primary outcome measures were: reduced time to full healing; reduced postoperative pain; reduced leakage rates from the dressing. Secondary outcome measures related to acceptability of the dressings to the patient. RESULTS: On removal of the dressings at the first assessment, 79% of the Tegaderm Absorbent donor sites had healed completely, compared with 16% of the Kaltostat ones (p<0.001).A significantly greater median area had healed with Tegaderm Absorbent (100%), when compared with Kaltostat (89%) (p<0.001). Mean time to complete healing was also significantly faster for Tegaderm Absorbent than Kaltostat (14 versus 21 days) (p<0.001). Significantly fewer subjects experienced postoperative pain with Tegaderm Absorbent on both day 1 (21% versus 67%, p=0.006, NNT=3) and day 2 (17% versus 75%, p<0.001, NNT=2). Leakage rates reduced by 48% with Tegaderm Absorbent, with no leakage in the smaller donor sites. Tegaderm Absorbent was significantly easier to apply than Kaltostat (89% versus 27% found it'very easy') as was ease of removal (84% versus 11% found it'very easy') (p<0.0001). Patients found Tegaderm Absorbent dressings significantly more convenient to manage and bathe with. At one month post-surgery, Vancouver scar scores showed thatTegaderm Absorbent donor sites were less red, flatter, softer and less itchy. CONCLUSION: Tegaderm Absorbent provides a significant improvement in terms of donor-site pain, healing and ease of management.
P J Terrill; R C W Goh; M J Bailey
Related Documents :
17620739 - Hyperbaric oxygen therapy mediates increased nitric oxide production associated with wo...
24023489 - Extracorporeal continuous portal diversion plus temporal plasmapheresis for "small-for-...
1993229 - The treatment of donor sites with cultured epithelial grafts.
24902809 - Protective effects of radix pseudostellariae extract against retinal laser injury.
6751459 - The lateral paramedian incision--experience with 850 cases.
23547939 - Is tubeless pcnl really less injurious than standard in the mid-term?
8087909 - Sugarless gum chewing before surgery does not increase gastric fluid volume or acidity.
19424749 - Is the retrojugular approach safer than the conventional approach for carotid endartere...
23063679 - Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of ...
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Journal of wound care     Volume:  16     ISSN:  0969-0700     ISO Abbreviation:  J Wound Care     Publication Date:  2007 Nov 
Date Detail:
Created Date:  2007-12-10     Completed Date:  2008-02-01     Revised Date:  2009-11-03    
Medline Journal Info:
Nlm Unique ID:  9417080     Medline TA:  J Wound Care     Country:  England    
Other Details:
Languages:  eng     Pagination:  433-8     Citation Subset:  N    
Department of Surgery, Monash University, Melbourne, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Alginates / adverse effects,  therapeutic use*
Clinical Nursing Research
Exudates and Transudates
Glucuronic Acid / adverse effects,  therapeutic use
Hexuronic Acids / adverse effects,  therapeutic use
Middle Aged
Occlusive Dressings / adverse effects,  standards*
Patient Acceptance of Health Care
Postoperative Care / instrumentation,  nursing
Prospective Studies
Skin Care / instrumentation*,  nursing
Skin Transplantation / adverse effects*
Thigh / surgery
Transplantation, Autologous / adverse effects
Treatment Outcome
Wound Healing*
Reg. No./Substance:
0/Alginates; 0/Hexuronic Acids; 0/Polyurethanes; 576-37-4/Glucuronic Acid; 9005-32-7/alginic acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Use of ultrasound to characterise the fluid-handling characteristics of four foam dressings.
Next Document:  Use of Dermabond tissue adhesive in hand surgery.